Sotera Health Co. (NASDAQ: SHC) reported Q3 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $226 million versus the consensus estimate of $221.61 million.

GUIDANCE:

Sotera Health Co. sees FY2021 EPS of $0.87-$0.88, versus the consensus of $0.89. Sotera Health Co. sees FY2021 revenue of $920-930 million, versus the consensus of $932 million.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.